Beta

    fda approve mdma for ptsd

    Before Jan 1, 2029

    fda approve mdma for ptsd. Best Yes near 49¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 49¢ · Best No: 56¢ · 1 platform

    • Kalshi: Yes 49¢ / No 56¢
    LIVE

    Before Jan 1, 2029

    Volume

    $83

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jan 1, 2029

    ~930 days left

    Category

    Culture

    49¢CHANCE OF YES47%53%
    Yes
    49¢
    Kalshi
    No
    56¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    49¢
    No
    56¢
    Vol
    $83
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2029, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 49¢: exit costs ~1.75¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jan 1, 2029
    Time Left930 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In